Kedrion Biopharma X – Gödöllö (Hungary)
Automation project of new production lines for the pharmaceutical plant. Execution of FAT, SAT and commissioning tests.

Kedrion produces and distributes human plasma-derived medicinal products used to treat and prevent rare and debilitating diseases and disorders. It now has a market presence in about 100 countries in Asia, Europe, and North and South America. With a plasma fractionation capacity of 600,000 liters and a dedicated workforce of around 200 people, the Gödöllő plant specializes in the production of intermediates for our life-saving Immunoglobulins and Human Albumin.